Artery Therapeutics, Inc
Artery Therapeutics, Inc., based in San Ramon, CA, is a clinical-stage biotechnology company focused on developing proprietary therapeutics for neurodegenerative diseases, particularly those driven by apolipoprotein E4 (ApoE4), such as Alzheimer's disease. Their innovative peptide library targets the ABCA1 transporter, aiming to alter cell membrane functionality and potentially reverse the effects of ApoE4-associated conditions.
In addition to their work in neurodegenerative diseases, Artery is also advancing a therapeutic molecule, Dipep, which addresses atherosclerosis and diabetes-related cardiovascular issues. With a strong emphasis on scientific research and development, the company is committed to meeting significant unmet medical needs in these critical health areas.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.